Search

everythinglearnresearchcommunity

for

Search:↓

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Enhancing melanin's energy generation may help treat alopecia areata.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Trichoscopy can help diagnose and monitor the progression of dissecting cellulitis.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

Different genes cause Female Pattern Hair Loss compared to male hair loss, and treatments vary, but more research is needed to understand it fully.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

Two new signs, 'signet ring vessels' and 'hidden hairs,' help tell apart scalp psoriasis and seborrheic dermatitis.

About 11% of patients with secondary syphilis had Syphilitic Alopecia, which usually improved with treatment.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

The workshop aimed to improve hair loss disorder diagnosis and understanding.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.